February 12, 2025 – Washington, D.C.
Robert F. Kennedy Jr. is poised to become the next Secretary of Health and Human Services (HHS) after the Senate reached a unanimous-consent agreement setting his final confirmation vote for 11 a.m. on February 13, 2025. The Senate’s 53-47 vote to end debate earlier today has paved the way for what is expected to be one of the most controversial confirmations of the Trump administration.
A High-Stakes, Polarizing Nomination
Kennedy’s appointment has drawn both intense support and fierce opposition from across the political spectrum. His nomination hearings focused heavily on his longstanding criticism of vaccines, the pharmaceutical industry, and federal health agencies, sparking heated debate over his fitness to lead the nation’s health department.
The unanimous-consent agreement ensured that Kennedy’s confirmation process moved forward without further delays, with procedural rules allowing post-cloture debate time to be counted from 1 a.m. on February 12, 2025. With Senate Republicans largely united in favor of Kennedy’s nomination, his final confirmation appears all but certain.
Supporters’ Case for RFK Jr.
1. Refocusing on Chronic Disease
Kennedy has argued that the federal government has over-prioritized infectious diseases while failing to address the growing burden of chronic illnesses like diabetes, heart disease, and autoimmune disorders. He has pledged to reform the CDC, FDA, and NIH, shifting focus toward preventative health, environmental factors, and food safety.
2. Holding Big Pharma and Health Bureaucracies Accountable
A well-known critic of the pharmaceutical industry, Kennedy has promised to take on corporate interests and increase transparency within the federal health agencies. His supporters believe he will curb the undue influence of pharmaceutical companies, rein in wasteful government spending, and advocate for medical freedom.
3. Bipartisan Populist Appeal
Kennedy’s independent streak has resonated with voters and lawmakers who distrust government overreach. His confirmation has drawn support from conservatives who view him as a reformer who will challenge the entrenched bureaucracy within HHS.
Critics’ Concerns Over Kennedy’s Leadership
1. Vaccine Controversy and Public Health Risks
Kennedy has been a vocal skeptic of vaccines, a position that has drawn sharp criticism from public health experts and Democratic lawmakers. Critics argue that his past statements could undermine vaccination efforts, erode public trust in HHS’s ability to combat infectious diseases, and reverse decades of progress in public health initiatives.
2. Opposition from Key Senate Democrats and Public Health Officials
Despite initially entertaining some of Kennedy’s ideas, Senator John Fetterman (D-PA) ultimately voted against his confirmation. Other Senate Democrats, including Senate Majority Leader Chuck Schumer (D-NY), have called Kennedy’s nomination “dangerous” and warned that his leadership could weaken the nation’s pandemic preparedness.
3. McConnell’s Potential ‘No’ Vote
Former Senate Majority Leader Mitch McConnell (R-KY), a polio survivor, has voiced concerns about Kennedy’s stance on vaccines, leading some to speculate that he may vote against the final confirmation. However, McConnell’s opposition would not be enough to block Kennedy, as all Republicans except for potential defectors remain supportive.
What Comes Next?
If confirmed, Kennedy will oversee the Department of Health and Human Services, which manages agencies like the CDC, FDA, and NIH, and administers programs such as Medicare and Medicaid. His appointment could signal a major shift in federal health policy, with new priorities on environmental health, corporate oversight, and chronic disease prevention.
With a final Senate vote set for February 13, 2025, all eyes will be on whether Kennedy’s nomination sparks further party-line divisions or if any last-minute defections shift the outcome.
Bills at the Hill 
Leave a comment